...
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Engineering liver tissue from induced pluripotent stem cells: A first step in generating new organs for transplantation?
【24h】

Engineering liver tissue from induced pluripotent stem cells: A first step in generating new organs for transplantation?

机译:从诱导的多能干细胞工程化肝组织:产生用于移植的新器官的第一步?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A critical shortage of donor organs for treating end-stage organ failure highlights the urgent need for generating organs from human induced pluripotent stem cells (iPSCs). Despite many reports describing functional cell differentiation, no studies have succeeded in generating a three-dimensional vascularized organ such as liver. Here we show the generation of vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro (iPSC-LBs). Specified hepatic cells (immature endodermal cells destined to track the hepatic cell fate) self-organized into three-dimensional iPSC-LBs by recapitulating organogenetic interactions between endo-thelial and mesenchymal cells. Immunostaining and gene-expression analyses revealed a resemblance between in vitro grown iPSC-LBs and in vivo liver buds. Human vasculatures in iPSC-LB transplants became functional by connecting to the host vessels within 48 hours. The formation of functional vasculatures stimulated the maturation of iPSC-LBs into tissue resembling the adult liver. Highly metabolic iPSC-derived tissue performed liver-specific functions such as protein production and human-specific drug metabolism without recipient liver replacement. Furthermore, mesenteric transplantation of iPSC-LBs rescued the drug-induced lethal liver failure model. To our knowledge, this is the first report demonstrating the generation of a functional human organ from pluripotent stem cells. Although efforts must ensue to translate these techniques to treatments for patients, this proof-of concept demonstration of organ-bud transplantation provides a promising new approach to study regenerative medicine.
机译:用于治疗晚期器官衰竭的供体器官的严重短缺凸显了迫切需要从人诱导的多能干细胞(iPSC)生成器官。尽管有许多报道描述了功能性细胞分化,但尚无研究成功产生三维血管化器官,例如肝脏。在这里,我们显示了通过移植体外创建的肝芽(iPSC-LBs)从人iPSC生成血管化和功能性人肝脏。通过概括内皮细胞和间充质细胞之间的有机遗传相互作用,将特定的肝细胞(旨在追踪肝细胞命运的未成熟内胚层细胞)自组织成三维iPSC-LB。免疫染色和基因表达分析揭示了体外生长的iPSC-LB与体内肝芽之间的相似之处。通过在48小时内连接到宿主血管,iPSC-LB移植中的人类脉管系统开始起作用。功能性脉管系统的形成刺激了iPSC-LBs进入类似于成人肝脏的组织的成熟。高度代谢的iPSC衍生组织在没有接受者肝脏替代的情况下执行肝脏特定的功能,例如蛋白质生产和人类特定的药物代谢。此外,iPSC-LBs的肠系膜移植挽救了药物诱发的致命性肝衰竭模型。据我们所知,这是第一份证明多能干细胞产生人体功能器官的报告。尽管必须进行努力才能将这些技术转化为患者的治疗方法,但这种器官预算移植的概念验证证明为研究再生医学提供了一种有希望的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号